Assistant Research Professor
Virginia Commonwealth University
I am Mohammad Momin an Assistant Research Professor in the Department of Pharmaceutics at the School of Pharmacy in Virginia Commonwealth University, USA. I received my Ph.D. in Pharmacy from University of Otago in New Zealand. Before starting my PhD, I worked more than 5 years in Pharmaceutical Industries. Immediately after my PhD, I started to work as a Postdoctoral Fellow under Professor Mike Hindle at Virginia Commonwealth University. My current research focuses on the development of high efficiency surfactant dry powder inhaler for both neonates and adults to treat respiratory distress syndrome (RDS) using our excipient enhanced growth (EEG) formulation technology. I published more than 40 peer-reviewed journal articles, over 10 peer-reviewed conference papers, three submitted patents, and 40 conference abstracts. I have also served as a co-guest editor of a special issue of Respiratory drug delivery section in Frontiers in Drug Delivery journal. I am the reviewer board member of MDPI journals and a member of American Association of Pharmaceutical Scientists (AAPS). I have also been reviewing articles for most of the Pharmaceutics journals including International Journal of Pharmaceutics (IJP), European Journal of Pharmaceutical Sciences (EJPS), and AAPS PhramSciTech. My PhD thesis has been awarded the “Exceptional Doctoral Thesis” in division of health sciences" University of Otago, New Zealand. In 2023, I have been awarded the best Postdoc poster winner in the “VCU School of Pharmacy 26th Annual Research Day”. I have also been awarded with several presentation awards including Second place winner in the 2023 VCU “Postdoc Data Slam competition”, Best student presentation award by New Zealand-Australian Controlled Release Society (NZAUS-CRS) in 2017, best student presentation winner in Otago Global Health Institute (OGHI) Conference in 2016 and first place in Three Minute Thesis (3MT) competition 2017 in the School of Pharmacy at University of Otago, New Zealand.